Metabolite Relaxation Times at 3T From Birth to 7 Years
Authors:
- Saipavitra Murali-ManoharSMSaipavitra Murali-Manohar
- Abdelrahman GadAGAbdelrahman Gad
- Zahra ShamsZSZahra Shams
- Gizeaddis L. SimegnGSGizeaddis L. Simegn
- Yulu SongYSYulu Song
- Aaron T. GudmundsonAGAaron T. Gudmundson
- Helge J. Zo□LlnerHZHelge J. Zo□Llner
- Christopher W. Davies-JenkinsCDChristopher W. Davies-Jenkins
- Dunja SimicicDSDunja Simicic
Preprint
Abstract
Purpose: With growing interest in pediatric MRS to understand the neurochemistry of brain development, it is essential to establish pediatric-specific metabolite T 1 and T 2 relaxation times for reliable quantification of metabolites. Furthermore, characterization of age-related changes in relaxation times may provide insight into developmental differences in tissue microstructure and cellular composition. Therefore, the goals of this study were two-fold: (1) to estimate metabolite T 1 and T 2 relaxation times in a pediatric cohort; and (2) to assess linear relationships between age and relaxation times. Methods: TI- and TE-series data were acquired from the bilateral thalamus in 20 and 25 participants aged between 0 and 7 years, respectively. Data were processed and modelled in Osprey 2.5.0. Metabolite T 1 and T 2 relaxation times of total N-acetylaspartate at 2.0 ppm (tNAA 2.0 ), total creatine at 3.0 ppm (tCr 3.0 ), total creatine at 3.9 ppm (tCr 3.9 ), total choline (tCho), myo-inositol (mI) and the combined glutamate and glutamine (Glx) were estimated by fitting the modelled signal amplitudes to TI-series inversion recovery signal and TE-series exponential decay equations, respectively. Linear relationships with age were tested for metabolite T 1 and T 2 relaxation times using Spearman correlations. Results: tNAA 2.0 and Glx showed significant changes in T 1 with age. tNAA 2.0 , tCr 3.0 , tCho and mI showed significant decrease in T 2 with age. Conclusion: Several metabolites showed significant changes in relaxation times with age in the thalamus region. Therefore, use of age-specific relaxation correction for pediatric studies using the linear equations provided is encouraged for reliable quantification of metabolites.Keywords
This publication has 33 references indexed in Scilit:
- The future is 2D: spectral‐temporal fitting of dynamic MRS data provides exponential gains in precision over conventional approachesMagnetic Resonance in Medicine, 2022
- MRSCloud: A cloud‐basedMRStool for basis set simulationMagnetic Resonance in Medicine, 2022
- Variation of T2 relaxation times in pediatric brain tumors and their effect on metabolite quantificationJournal of Magnetic Resonance Imaging, 2018
- In vivo estimation of transverse relaxation time constant (T2) of 17 human brain metabolites at 3TMagnetic Resonance in Medicine, 2018
- Use of tissue water as a concentration reference for proton spectroscopic imagingMagnetic Resonance in Medicine, 2006
- Proton spectroscopic metabolite signal relaxation times in preterm infants: A prerequisite for quantitative spectroscopy in infant brainJournal of Magnetic Resonance Imaging, 2003
- Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopyMagnetic Resonance in Medicine, 2002
- Metabolite concentrations in the developing brain estimated with proton MR spectroscopyJournal of Magnetic Resonance Imaging, 1994
- T1, T2, and concentrations of brain metabolites in neonates and adolescents estimated with H‐1 MR spectroscopyJournal of Magnetic Resonance Imaging, 1994
- Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopyMagnetic Resonance in Medicine, 1993